Skip to content

The Cerebral responses to acupuncture treating for Functional Dyspepsia Patients

The Cerebral responses to acupuncture treating for Functional Dyspepsia Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11003028
Enrollment
Unknown
Registered
2011-07-21
Start date
2008-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia

Interventions

A:The treatment consisted of 20 sessions of acupuncture treatment, with a duration of 30 min, each administered over a period of 4 weeks (five sessions per week). Th e acupuncture treatment was perfor
B:The treatment consisted of 20 sessions of acupuncture treatment, with a duration of 30 min, each administered over a period of 4 weeks (five sessions per week). Th e acupuncture treatment was perfor
C: The treatment consisted of 20 sessions of acupuncture treatment, with a duration of 30 min, each administered over a period of 4 weeks (five sessions per week). Th e acupuncture treatment was perf
D:The treatment consisted of 20 sessions of acupuncture treatment, with a duration of 30 min, each administered over a period of 4 weeks (five sessions per week). Th e acupuncture treatment was perfor

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. 20 to 30 of age, right handedness; 2. To be with Functional Dyspepsia (FD) confirmed by diagnostic criteria Rome III; 3. To be with the type of post-dinner discomfort syndrome (PDS) of FD.

Exclusion criteria

Exclusion criteria: 1. pregnant woman or plan to pregnant, or during lactation, or 2. suffering from or had a history of serious neurological, cardiovascular, respiratory or renal illnesses, or 3. having a history of gastrointestinal surgery, dysmenorrheal, diabetes or head trauma with loss of consciousness, or 4. suffering from mental disorders including major depressive disorder, anxiety disorder, bipolar disorder, schizophrenia, claustrophobic syndrome, etc., or 5. having been using aspirin, non-steroidal anti-inflammatory drugs, steroids, phenothiazines, selective serotonin reuptake inhibitors or medication affecting gastrointestinal motility, etc. for over 2 weeks before enrollment, or 6. have been involved in other clinical trials in past two months.

Design outcomes

Primary

MeasureTime frame
Cerebral glucometabolism;Nepean Dyspepsia Index (NDI);Symptoms Index of Dyspepsis;

Countries

China

Contacts

Public ContactFanrong Liang
lfr@cdutcm.edu.cn+86 13608058316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026